News | July 16, 2008

Researchers Develop Computer-Aided Classification of Heart Sounds Not Detectable to the Human Ear

July 17, 2008 - Heart sounds provide valuable diagnostic information concerning the heart valves and hemodynamics of heart, but the poor sensitivity of human ears in the low frequency range makes this task difficult, so two researchers have created a computer-aided phonocardiogram (PCG) to analyze a digitized recordings of heart sounds.

Certain heart diseases are best detected only by auscultation. The collection of sonic waves from the surface of the body, as performed with the stethoscope, continues to provide an important source of clinical information that, together with the overall bedside examination, is cost-effective and also cannot be totally replaced by alternative technical methods like echocardiography. Moreover, echocardiography is not required for all patients with systolic murmurs. However, it is reported that a disturbing percentage of medical graduates cannot properly diagnose heart conditions using stethoscope.

For this reason, researchers Samit Ari and Goutam Saha of the at Indian Institute of Technology’s Department of Electronics and Electrical Communication Engineering in Kharagpur, India developed a computer-aided stethoscope to more accurately analyze heart sounds. Their findings are explained in the inaugural issue of the International Journal of Medical Engineering and Informatics in published in July.

Their system extracts robust acoustic features for automatic classification of heart sounds based on empirical mode decomposition (EMD). The work decomposes segmented heart sound cycles with EMD to generate certain intrinsic mode functions (IMF). The first IMF contains mostly high frequency noise, the second and third IMFs carry higher frequency components of signals of interest and the residue contains its low frequency components. The system examines 25 dimensional feature vectors,

They conducted experiments on 104 different recordings of heart sound comprising of normal and 12 different pathological cases against three different additive background noises - white Gaussian, hospital and body noise. It is found that the EMD based feature extraction always performed better than benchmark wavelet based feature extraction technique.

The acoustic energy produced by the mechanical activity of the heart can produce tell-tale sounds of abnormalities in cardiac components and manifest itself in the corresponding sounds in the PCG. Unlike echocardiography, the non-invasive cardiac auscultation is simple, cost-effective and with proper signal processing and pattern recognition tools may emerge as an important device for primary detection of heart valve disorders, the researchers said.
A cardiac cycle primarily contains two major sounds – first heart sound (S1) followed by second heart sound (S2). The intervals between S1 and S2 (systole), and S2 and S1 (diastole) of the next cycle are usually silent for normal cases. These two distinct normal heart sounds are often described as lub and dub (or dup), and occur in sequence with each heartbeat. In an abnormal heart sounds there could be several other sounds in the PCG signal besides primary heart sounds. Abnormal heart murmurs, if present in the cardiac cycle, refer to different pathological conditions as per location, shape, duration and other associated features. Murmurs are generally high frequency, noise-like sounds that arise when the velocity of blood become high when it flows through an irregularity. The PCG signal has been widely used to detect the cardiac abnormalities. Different features of PCG signals like intensity, frequency content, split information, time relations, etc. can give an idea of the underlying pathology, if any, and the state of the heart function.

For more information: www.inderscience.com

Related Content

New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
Overlay Init